A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07) | MicrobiomeTrials
A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-06-15Est. Completion: 2029-12
Enrollment target: 562 participants
Locations
Henan Cancer Hospital, Zhengzhou, Henan, China
Shanghai East Hospital, Shanghai, Shanghai Municipality, China